#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	522	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1202	23.2	0	.	p	.	0	K29T	NONSYN	85	87	AAG	369	371	ACG	24;24;23	A;C;G	24;24;23	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1458	1460	AGC	42;44;46	A,G;G;C	28,14;44;46	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	L121Q	0	.	.	361	363	CTG	639	641	CTG	87;87;85	C;T;G	87;87;84	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	Q125K	0	.	.	373	375	CAG	651	653	CAG	93;97;97	C;A;G	93;94;96	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	Q125R	0	.	.	373	375	CAG	651	653	CAG	93;97;97	C;A;G	93;94;96	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	Q125E	0	.	.	373	375	CAG	651	653	CAG	93;97;97	C;A;G	93;94;96	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	Y161C	0	.	.	481	483	TAC	759	761	TAC	92;91;93	T;A;C	92;91;93	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	Y161D	0	.	.	481	483	TAC	759	761	TAC	92;91;93	T;A;C	92;91;93	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	Y161N	0	.	.	481	483	TAC	759	761	TAC	92;91;93	T;A;C	92;91;93	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1404	1406	GCA	78;76;76	G,A;C;A	75,1;75;76	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1404	1406	GCA	78;76;76	G,A;C;A	75,1;75;76	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1413	1415	GAA	78;76;77	G;A;A	78;74;76	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	0	HET	.	.	.	C216T,A	.	216	216	C	494	494	C	100	C,T,A	67,31,1	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	0	HET	.	.	.	C954T	.	954	954	C	1232	1232	C	97	C,T	62,34	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	0	HET	.	.	.	C99T	.	99	99	C	377	377	C	42	C,T	21,21	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	667	2136	Escherichia_coli_EF_Tu	1185	1185	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1705	65.0	0	HET	.	.	.	T135C	.	135	135	T	413	413	T	61	T,C	32,26	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	744	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1822	21.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1603	1605	AAA	9;9;8	A;A;A	9;9;8	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1026	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1769	30.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1245	1247	GAA	46;47;46	G;A;A	45;47;46	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	198	H_NS	414	414	99.03	H_NS.l15.c17.ctg.1	679	15.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	127	G	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	131	T	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	169	G	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	164	C	163	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	151	C,A	150,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	156	T	154	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	143	C	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	122	C	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	129	A	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	129	A	129	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	126	A	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	126	T	124	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	126	C	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	113	C	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	113	A	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	111	G	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	112	C	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	125	T	125	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	143	G	143	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	148	G	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	151	T	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	153	T	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	150	G	149	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	100	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	94	A	93	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	54	C	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	7	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	7	A	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	8	G	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	9	C	9	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	46	T	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	54	G	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	56	T	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	151	C	150	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2844	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.1	797	93.3	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	114	C,T	61,30	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	796	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1367	30.1	0	.	p	.	0	H2R	NONSYN	4	6	CAT	233	235	CGT	18;18;18	C;G;T	18;18;18	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	796	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1367	30.1	0	.	p	.	0	V30I	NONSYN	88	90	GTC	317	319	ATC	27;26;26	A;T;C	27;26;26	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	796	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1367	30.1	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1076	1078	GGC	23;22;22	G;G;C	23;22;22	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2028	27.8	0	.	p	.	0	R8S	NONSYN	22	24	AGA	188	190	AGC	13;13;13	A;G;C	13;13;13	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2028	27.8	0	.	p	.	0	I142L	NONSYN	424	426	ATA	590	592	CTA	27;27;27	C;T;A	27;27;27	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2028	27.8	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1109	1111	CAA	36;38;39	C;A;A	36;38;39	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2028	27.8	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1208	1210	GGT	35;33;33	G;G;T	35;33;33	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1066	PmrC	1644	1644	99.15	PmrC.l6.c30.ctg.1	2028	27.8	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1778	1780	GTT	18;17;17	G;T;T	18;17;17	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	456	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1706	14.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	656	658	GAA	14;14;14	G;A;A	14;14;14	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	456	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1706	14.2	0	.	p	.	0	M185T	NONSYN	553	555	ATG	836	838	ACC	7;7;7	A;C;C	7;7;7	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	456	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1706	14.2	0	.	p	.	0	S225T	NONSYN	673	675	TCC	956	958	ACT	12;12;12	A;C;T	12;11;12	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	456	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1706	14.2	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1346	1348	ATC	12;13;13	A;T;C	12;13;13	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	550	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1396	20.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	56	TEM_1+	858	163	98.77	TEM_1+.l15.c30.ctg.1	163	4.2	0	.	p	.	0	F19L	NONSYN	55	57	TTT	26	28	CTT	4;4;4	C;T;T	4;4;4	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	56	TEM_1+	858	212	99.53	TEM_1+.l15.c30.ctg.2	217	3.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	672	aad-	789	789	100.0	aad-.l6.c4.ctg.1	1366	26.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1956	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3622	28.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	580	582	ATC	22;21;19	A;T;C	22;21;19	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1956	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3622	28.8	0	.	p	.	0	V416I	NONSYN	1246	1248	GTC	1573	1575	ATC	29;29;30	A;T;C	29;29;29	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1956	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3622	28.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2293	2295	AAG	17;18;19	A;A;G	17;18;19	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	834	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1609	27.5	0	.	p	.	0	A22V	NONSYN	64	66	GCC	247	249	GTC	7;6;7	G;T;C	7;6;7	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	834	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1609	27.5	0	.	p	.	0	S269C	NONSYN	805	807	AGC	988	990	TGC	45;47;43	T;G;C	45;47;42	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1780	acrF	3105	2598	98.04	acrF.l15.c30.ctg.1	3001	31.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	344	344	T	20	T	20	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1780	acrF	3105	2598	98.04	acrF.l15.c30.ctg.1	3001	31.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	650	652	GAC	30;29;29	G;A;C	30;28;29	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1780	acrF	3105	2598	98.04	acrF.l15.c30.ctg.1	3001	31.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	926	928	TTA	14;14;13	T;TAAAAAA,TAAAAA;A	14;12,1;13	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1780	acrF	3105	2598	98.04	acrF.l15.c30.ctg.1	3001	31.5	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1109	1111	AAT	27;27;25	A;A;T	27;27;25	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1780	acrF	3105	2598	98.04	acrF.l15.c30.ctg.1	3001	31.5	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1896	1896	T	49	T	49	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	428	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1084	20.8	1	SNP	p	R45C	0	.	.	133	135	CGC	379	381	CGC	22;22;24	C;G;C	22;22;24	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	358	acrS	663	663	98.64	acrS.l15.c17.ctg.1	1000	19.0	0	.	p	.	0	L34F	NONSYN	100	102	CTC	216	218	TTC	24;24;24	T;T;C	24;24;24	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	358	acrS	663	663	98.64	acrS.l15.c17.ctg.1	1000	19.0	0	.	p	.	0	E122G	NONSYN	364	366	GAG	480	482	GGG	15;13;13	G;G;G	15;13;13	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	462	adiY	762	762	99.61	adiY.l15.c17.ctg.1	1198	20.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	627	629	CTT	40;39;41	C;T;T	40;39;41	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2024	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3145	34.5	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2112	2114	GCA	45;50;50	G;C;A	44;50;50	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2024	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3145	34.5	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2373	2375	ACC	45;47;45	A;C;C	45;47;45	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2024	alaS	2631	2631	98.86	alaS.l6.c30.ctg.1	3145	34.5	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2682	2684	GCC	33;32;32	G;C;C	33;32;32	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	G37A	NONSYN	109	111	GGT	290	292	GCT	10;12;13	G;C;T	10;12;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	D77E	NONSYN	229	231	GAT	410	412	GAG	7;7;7	G;A;G	7;7;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	446	448	TGC	9;9;9	T;G;C	9;9;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	I150V	NONSYN	448	450	ATT	629	631	GTT	19;18;20	G;T;T	18;17;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	R200H	NONSYN	598	600	CGC	779	781	CAC	16;15;15	C;A;C	16;15;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1064	1066	ATG	38;39;39	A;T;G	37;38;38	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	932	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2437	20.5	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2060	2062	CGC	20;17;16	C;G;C	20;17;16	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	364	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1326	14.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	948	950	ACC	8;8;7	A;C;C	8;8;7	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	364	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1326	14.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	960	962	TCG	7;7;7	T;C;G	7;7;7	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	438	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1154	20.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	700	baeS	1404	1404	98.86	baeS.l15.c4.ctg.2	1629	22.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1338	1340	AAA	19;19;19	A;A;A	14;19;18	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	700	baeS	1404	1404	98.86	baeS.l15.c4.ctg.2	1629	22.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1350	1352	GAG	14;14;15	G;A;G	11;10;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	700	baeS	1404	1404	98.86	baeS.l15.c4.ctg.2	1629	22.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1356	1358	CAC	15;15;15	C;A;C	14;15;14	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	700	baeS	1404	1404	98.86	baeS.l15.c4.ctg.2	1629	22.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1410	1412	GAG	19;19;20	G;A;G	19;19;20	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	976	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1781	29.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	524	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1196	23.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	592	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1348	23.2	0	.	p	.	0	A146T	NONSYN	436	438	GCT	645	647	ACT	25;26;26	A;C;T	25;26;26	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	322	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	747	21.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	794	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1659	25.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	907	909	GTC	57;57;58	G;T;C	57;56;58	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1116	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2020	29.6	0	.	p	.	0	E197K	NONSYN	589	591	GAA	855	857	AAA	33;33;35	A;A;A	33;33;35	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	774	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1610	25.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	839	841	AGC	17;18;17	A;G;C	17;18;17	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	542	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1519	19.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	738	740	AGG	16;16;16	A;G;G	16;16;16	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	542	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1519	19.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1128	1130	GAC	16;16;16	G;A;C	16;16;16	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	410	emrR	531	531	100.0	emrR.l6.c4.ctg.1	982	22.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	722	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2022	19.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	304	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1092	14.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	420	422	CTG	11;11;11	C;T;G	11;11;11	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	T38I	NONSYN	112	114	ACA	230	232	ATA	5;5;3	A;T;A	5;5;3	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	L42V	NONSYN	124	126	CTA	242	244	GTA	11;11;11	G;T;A	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	A93T	NONSYN	277	279	GCG	395	397	ACG	17;17;16	A;C;G	17;17;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	A114E	NONSYN	340	342	GCA	458	460	GAA	13;13;13	G;A;A	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	T127A	NONSYN	379	381	ACT	497	499	GCT	11;10;10	G;C;T	11;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	N133D	NONSYN	397	399	AAT	515	517	GAT	10;9;9	G;A;T	10;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	P162S	NONSYN	484	486	CCA	602	604	TCA	6;6;6	T;C;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	731	733	CAG	8;7;7	C;A;G	8;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	I251V	NONSYN	751	753	ATT	869	871	GTT	20;20;20	G;T;T	19;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1025	1027	GAT	13;13;13	G;A;T	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1193	1195	AAT	8;8;8	A;A;T	8;8;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1214	1216	TTA	2;2;2	T;T;A	2;2;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1415	1417	AAA	13;13;13	A;A;A	13;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2150	2152	CAT	15;15;15	C;A;T	15;15;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2204	2206	CAT	10;11;11	C;A;T	10;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2222	2224	AGA	10;11;11	A;G;A	10;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2237	2239	AAT	15;16;16	A;A;T	15;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2384	2386	TCC	11;10;12	T;C;C	11;10;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2549	2551	ATT	30;29;29	A;T;T	30;29;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2570	2572	GAT	32;31;32	G;A;T	32;31;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2684	2686	GTT	26;26;27	G;T;T	26;26;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1484	evgS	3594	3594	97.52	evgS.l6.c4.ctg.1	3943	19.8	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	2969	2971	CAC	22;22;21	C;A;C	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	556	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1278	23.1	1	SNP	p	P64S	0	.	.	190	192	CCA	412	414	CCA	52;53;53	C;C;A	52;53;51	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	556	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1278	23.1	1	SNP	p	P64A	0	.	.	190	192	CCA	412	414	CCA	52;53;53	C;C;A	52;53;51	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	556	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1278	23.1	1	SNP	p	P64H	0	.	.	190	192	CCA	412	414	CCA	52;53;53	C;C;A	52;53;51	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	556	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1278	23.1	1	SNP	p	P64R	0	.	.	190	192	CCA	412	414	CCA	52;53;53	C;C;A	52;53;51	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	556	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1278	23.1	1	SNP	p	P64L	0	.	.	190	192	CCA	412	414	CCA	52;53;53	C;C;A	52;53;51	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	306	gadE	528	528	100.0	gadE.l15.c30.ctg.1	954	16.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	100	gadW	729	155	96.77	gadW.l15.c4.ctg.1	155	13.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	100	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	7.3	0	.	p	.	0	D100E	NONSYN	298	300	GAC	14	16	GAA	2;2;2	G;A;A	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	100	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	7.3	0	.	p	.	0	P101S	NONSYN	301	303	CCC	17	19	TCC	2;2;2	T;C;C	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	100	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	7.3	0	.	p	.	0	R102G	NONSYN	304	306	CGG	20	22	GGG	2;2;2	G;G;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	100	gadW	729	171	92.98	gadW.l15.c4.ctg.3	171	7.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	44	46	AAT	4;4;4	A;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	362	gadX	825	809	98.02	gadX.l15.c4.ctg.2	878	19.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	141	143	TTA	11;11;11	T;T;A	11;11;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	362	gadX	825	809	98.02	gadX.l15.c4.ctg.2	878	19.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	219	221	ATT	11;12;13	A;T;T	11;12;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	362	gadX	825	809	98.02	gadX.l15.c4.ctg.2	878	19.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	720	722	GGA	14;16;17	G;G;A	13;16;17	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	531	362	gadX	825	809	98.02	gadX.l15.c4.ctg.2	878	19.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	726	728	CCG	17;16;16	C;C;G	17;16;16	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2268	2270	GAA	35;36;36	G;A;A	35;36;36	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	S83I	0	.	.	247	249	TCG	483	485	TCG	39;39;40	T;C;G	39;39;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	S83W	0	.	.	247	249	TCG	483	485	TCG	39;39;40	T;C;G	39;39;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	S83L	0	.	.	247	249	TCG	483	485	TCG	39;39;40	T;C;G	39;39;40	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	D87G	0	.	.	259	261	GAC	495	497	GAC	35;35;34	G;A;C	35;35;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	D87N	0	.	.	259	261	GAC	495	497	GAC	35;35;34	G;A;C	35;35;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	D87H	0	.	.	259	261	GAC	495	497	GAC	35;35;34	G;A;C	35;35;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	495	497	GAC	35;35;34	G;A;C	35;35;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1872	gyrA_7	2628	2628	98.71	gyrA_7.l6.c30.ctg.1	3128	32.1	1	SNP	p	D87V	0	.	.	259	261	GAC	495	497	GAC	35;35;34	G;A;C	35;35;34	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136S	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136G	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136E	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136C	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136H	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136I	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1512	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2834	28.1	1	SNP	p	R136L	0	.	.	406	408	CGC	661	663	CGC	27;25;26	C;G;C	26;25;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	310	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1146	14.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	515	517	CCG	16;15;14	C;C;G,T	16;15;13,1	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	310	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1146	14.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	668	670	GCC	24;23;23	G;C;C	24;23;23	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	618	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1319	24.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	208	210	TCA	25;25;27	T;C;A	25;25;27	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	200	marA	384	384	99.74	marA.l6.c4.ctg.1	844	12.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	493	495	AGC	16;15;15	A;G;C	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	595	597	CAT	8;7;7	C;A;T	8;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	V45E	0	.	.	133	135	GTG	319	321	GTG	17;17;17	G;T;G	17;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	I49S	0	.	.	145	147	ATC	331	333	ATC	16;16;15	A;T;C	14;16;15	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	A70T	0	.	.	208	210	GCA	394	396	GCA	14;14;15	G;C;A	14;14;15	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	R73S	0	.	.	217	219	CGT	403	405	CGT	14;14;14	C;G;T	13;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	R73C	0	.	.	217	219	CGT	403	405	CGT	14;14;14	C;G;T	13;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	R77C	0	.	.	229	231	CGC	415	417	CGC	13;13;12	C;G;C	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	R77L	0	.	.	229	231	CGC	415	417	CGC	13;13;12	C;G;C	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	L78M	0	.	.	232	234	CTG	418	420	CTG	12;11;11	C;T;G	12;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	R94H	0	.	.	280	282	CGC	466	468	CGC	13;13;13	C;G;C	13;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	R94S	0	.	.	280	282	CGC	466	468	CGC	13;13;13	C;G;C	13;12;13	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	150	marR	435	435	97.7	marR.l6.c30.ctg.1	770	10.3	1	SNP	p	V96E	0	.	.	286	288	GTA	472	474	GTA	14;14;14	G;T;A	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	27	29	GAT	4;4;4	G;A;T	4;4;4	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	48	50	ACC	6;6;7	A;C;C	6;6;7	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	75	77	TTA	8;8;8	T;T;A	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	216	218	CAG	19;20;20	C;A;G	19;20;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	255	257	GCC	21;20;21	G;C;C	21;20;21	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	360	362	GCG	31;31;28	G;C;G	31;30;28	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	564	566	GTT	20;20;20	G;T;T	19;20;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	1104	97.46	mdfA.l15.c4.ctg.1	1335	17.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	726	726	C	13	C	13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	513	462	mdfA	1233	93	96.77	mdfA.l15.c4.ctg.2	93	7.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	80	82	ATC	3;3;3	A;T;C	3;3;3	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	530	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1640	17.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	242	242	G	22	G	22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	530	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1640	17.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	299	301	CAG	10;10;10	C;A;G	10;9;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	530	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1640	17.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	449	451	ATC	17;17;17	A;T;C	17;17;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	530	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1640	17.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	497	499	ATG	10;10;10	A;T;G	10;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	530	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1640	17.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	590	592	ACC	13;14;14	A;C;C	13;14;14	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	530	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1640	17.2	0	.	p	.	0	P257T	NONSYN	769	771	CCG	971	973	ACG	9;9;9	A;C;G	9;9;9	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1958	1960	ACC	33;31;31	A;C;C	33;31;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2351	2353	CAA	24;25;24	C;A;A	24;25;24	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2519	2521	ATT	17;16;16	A;T;T	17;16;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2603	2605	GTT	35;35;34	G;T;T	35;35;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2711	2713	GAG	24;24;22	G;A;G	23;23;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2939	2941	ATG	19;22;22	A;T;G	19;22;22	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1964	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3567	29.3	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3074	3076	GAT	28;28;29	G;A;T	28;28;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1922	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3151	31.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	187	189	ATG	20;20;19	A;T;G	20;20;18	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1922	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3151	31.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	673	675	ATC	33;35;36	A;T;C,A	33;35;35,1	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1922	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3151	31.8	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	2989	2991	CAC	6;5;5	C;A;C	6;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1922	mdtC	3078	3078	98.64	mdtC.l15.c17.ctg.1	3151	31.8	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	2992	2994	CTC	5;5;5	C;T;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	780	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	22.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	179	181	GAA	11;10;11	G;A;A	11;10;11	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	780	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	22.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	848	850	GCG	27;28;28	G;C;G	27;28;28	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	780	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	22.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1190	1192	ATC	25;25;26	A;T;C	25;25;26	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	780	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1827	22.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1493	1495	TTT	26;26;26	T;T;T	26;26;26	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	880	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1658	28.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2070	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3556	31.0	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1089	1091	ACC	24;22;22	A;C;C	24;21;22	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2070	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3556	31.0	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2331	2333	GAC	35;34;34	G;A;C	34;33;34	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	730	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1566	21.2	0	.	p	.	0	V200I	NONSYN	598	600	GTC	688	690	ATC	22;23;24	A;T;C	22;23;24	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	730	mdtG	1227	176	99.43	mdtG.l15.c4.ctg.2	411	10.6	0	.	p	.	0	E5G	NONSYN	13	15	GAA	7	9	GGA	3;3;4	G;G;A	3;3;4	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	630	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1624	20.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	576	578	TGT	25;25;25	T;G;T	25;25;25	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	630	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1624	20.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1146	1148	TTG	22;22;22	T;T;G	22;22;22	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	630	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1624	20.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1356	1358	ACG	11;12;12	A;C;G	11;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	812	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1642	26.3	0	.	p	.	0	A185S	NONSYN	553	555	GCC	810	812	TCC	29;29;30	T;C;C	28;29;30	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	574	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1501	20.4	0	.	p	.	0	V119I	NONSYN	355	357	GTT	557	559	ATT	22;24;24	A;T;T	22;23;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	V11M	NONSYN	31	33	GTG	176	178	ATG	16;16;16	A;T;G	16;16;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	T33I	NONSYN	97	99	ACC	242	244	ATC	27;25;24	A;T;C	27;25;24	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	C116R	NONSYN	346	348	TGC	491	493	CGC	36;34;33	C;G;C	35;34;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	N238S	NONSYN	712	714	AAC	857	859	AGC	29;28;26	A;G;C	29;27;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1058	1060	GTG	27;28;28	G;T;G	27;27;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1121	1123	AAC	12;12;13	A;A;C	12;12;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1166	1168	GTC	21;21;21	G;T;C	21;21;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1196	1198	ATA	40;40;39	A;T;A	40;40;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1304	1306	TCT	22;20;21	T;C;T	22;20;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1691	1693	GCG	34;34;34	G;C;G	33;33;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1320	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2412	29.1	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1904	1906	ATC	32;33;33	A;T;C	32;32;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	S129A	NONSYN	385	387	TCA	679	681	GCG	17;17;18	G;C;G	17;16;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	A187T	NONSYN	559	561	GCC	853	855	ACC	14;14;13	A;C;C	14;14;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	H211R	NONSYN	631	633	CAC	925	927	CGC	25;25;25	C;G;C	25;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1042	1044	GCT	21;21;20	G;C;T	21;21;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1126	1128	AAA	10;10;10	A;A;A	10;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1144	1146	CGA	12;12;12	C;G;A	12;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1309	1311	GCC	14;14;14	G;C;C	14;14;14	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1321	1323	GAT	15;15;16	G;A;T	15;15;16	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	718	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1953	19.6	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1738	1740	GCT	11;10;10	G;C;T	11;10;10	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2046	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3836	28.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1527	1529	AAG	13;14;13	A;A;G	13;14;13	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2046	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3836	28.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2604	2606	CTG	32;33;33	C;T;G	32;33;33	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	126	mgrB	144	144	100.0	mgrB.l15.c30.ctg.3	166	20.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1222	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2177	30.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1014	1016	AAC	24;24;25	A;A;C	24;24;25	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1222	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2177	30.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1560	1562	ATA	27;28;27	A;T;A	27;28;27	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	942	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1730	28.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1314	1316	GAT	43;43;43	G;A;T	43;41;40	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	942	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1730	28.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1317	1319	CTG	46;47;47	C;T;G	45;47;46	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	220	nfsA	723	405	99.01	nfsA.l15.c17.ctg.1	724	15.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	147	149	TGT	18;17;17	T;G;T	18;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	220	nfsA	723	405	99.01	nfsA.l15.c17.ctg.1	724	15.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	417	419	ACC	21;21;21	A;C;C	21;21;21	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	220	nfsA	723	405	99.01	nfsA.l15.c17.ctg.1	724	15.6	1	SNP	p	R15C	0	.	.	43	45	CGC	111	113	CGC	30;30;30	C;G;C	30;30;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	220	nfsA	723	405	99.01	nfsA.l15.c17.ctg.1	724	15.6	1	SNP	p	S33R	0	.	.	97	99	AGC	165	167	AGC	8;8;8	A;G;C	8;8;8	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	528	220	nfsA	723	405	99.01	nfsA.l15.c17.ctg.1	724	15.6	1	SNP	p	G131D	0	.	.	391	393	GGC	459	461	GGC	18;17;17	G;G;C	18;17;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	770	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1456	27.5	0	.	p	.	0	D312E	NONSYN	934	936	GAT	991	993	GAG	36;36;36	G;A;G	36;36;36	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	770	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1456	27.5	1	SNP	p	G141E	0	.	.	421	423	GGT	478	480	GGT	33;32;31	G;G;T	33;32;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	770	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1456	27.5	1	SNP	p	G141D	0	.	.	421	423	GGT	478	480	GGT	33;32;31	G;G;T	33;32;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	770	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1456	27.5	1	SNP	p	R154A	0	.	.	460	462	CGT	517	519	CGT	33;33;34	C;G;T	33;33;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	770	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1456	27.5	1	SNP	p	R154D	0	.	.	460	462	CGT	517	519	CGT	33;33;34	C;G;T	33;33;34	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1730	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	33.6	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1850	1852	GTG	40;40;40	G;T;G	40;40;40	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1730	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	33.6	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1877	1879	TCG	37;40;42	T;C;G	32;37;39	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1730	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	33.6	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2492	2494	AAC	20;19;19	A;A;C	20;19;19	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1730	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	33.6	1	SNP	p	A85T	0	.	.	253	255	GCG	506	508	GCG	45;43;43	G;C;G	45;43;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1730	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	33.6	1	SNP	p	D111H	0	.	.	331	333	GAT	584	586	GAT	38;38;38	G;A;T	38;38;38	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1730	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2754	33.6	1	SNP	p	S129P	0	.	.	385	387	TCC	638	640	TCC	31;30;31	T;C;C	31;30;31	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	944	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2140	22.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1440	1442	AAC	16;17;17	A;A;C	16;17;17	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	944	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2140	22.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1449	1451	GAT	18;18;17	G;A;T	18;18;17	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1050	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1928	29.0	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	871	873	CAG	33;35;35	C;A;G	33;35;35	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1050	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1928	29.0	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1345	1347	GAT	36;35;37	G;A;T	36;35;37	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	V146F	0	.	.	436	438	GTT	667	669	GTT	26;25;23	G;T;T	26;25;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1768	1770	CAG	41;38;38	C;A;G	40;38;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1768	1770	CAG	41;38;38	C;A;G	40;38;38	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1807	1809	CAC	44;42;43	C;A;C	44;42;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1816	1818	CGT	41;41;40	C;G;T	41;41;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1816	1818	CGT	41;41;40	C;G;T	41;41;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1822	1824	TCC	37;37;37	T;C;C	37;37;37	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1828	1830	CTC	31;30;29	C;T;C	31;30;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1918	1920	ACC	38;40;40	A;C;C	38;40;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1921	1923	CCT	40;40;39	C;C;T	40;40;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3094	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4523	36.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2290	2292	CGT	73;72;72	C;G;T	71;71;71	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	808	195.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	175	A	174	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	808	195.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	175	A	174	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.1	808	195.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	175	A	174	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	.	n	.	0	A226G	SNP	226	226	A	361	361	G	292	G,A	291,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	1	SNP	n	A794T	0	.	.	794	794	A	929	929	A	195	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	1	SNP	n	A794G	0	.	.	794	794	A	929	929	A	195	A	190	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	1	SNP	n	G926A	0	.	.	926	926	G	1061	1061	G	257	G	256	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	1	SNP	n	G926C	0	.	.	926	926	G	1061	1061	G	257	G	256	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	1	SNP	n	G926T	0	.	.	926	926	G	1061	1061	G	257	G	256	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	T90C	.	90	90	T	225	225	T	209	T,C	168,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	A250T	.	250	250	A	385	385	A	255	A,T	193,59	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	G474A	.	474	474	G	609	609	G	261	G,A	195,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	A253T,G	.	253	253	A	388	388	A	259	A,T,G	198,59,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	C194T	.	194	194	C	329	329	C	233	C,T	191,41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	A79G	.	79	79	A	214	214	A	222	A,G	172,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	C719T	.	719	719	C	854	854	C	228	C,T	130,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	T273A	.	273	273	T	408	408	T	229	T,A	174,48	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1136	217.9	0	HET	.	.	.	C183T	.	183	183	C	318	318	C	222	C,T	149,67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	143	100.0	rrsB+.l15.c30.ctg.3	143	53.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	37.9	0	.	n	.	0	G1002A	SNP	1002	1002	G	52	52	A	68	A	68	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	37.9	0	.	n	.	0	G1006C	SNP	1006	1006	G	56	56	C	70	C	70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	37.9	0	.	n	.	0	T1010C	SNP	1010	1010	T	60	60	C	71	C	70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	37.9	0	.	n	.	0	A1019.	DEL	1019	1019	A	68	68	G	70	G	70	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	37.9	0	.	n	.	0	.1023G	INS	1023	1023	T	73	73	G	65	G	64	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8146	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	37.9	0	.	n	.	0	C1038T	SNP	1038	1038	C	88	88	T	59	T	58	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	518	sat_1	525	525	100.0	sat_1.l15.c30.ctg.1	1045	26.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	400	soxR	465	465	100.0	soxR.l15.c17.ctg.1	841	24.8	1	SNP	p	R20H	0	.	.	58	60	CGC	225	227	CGC	45;44;45	C;G;C	44;44;45	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	400	soxR	465	465	100.0	soxR.l15.c17.ctg.1	841	24.8	1	SNP	p	G121D	0	.	.	361	363	GGT	528	530	GGT	24;25;24	G;G;T	24;25;24	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	278	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	852	17.4	1	SNP	p	A12S	0	.	.	34	36	GCA	304	306	GCA	31;32;33	G;C;A	31;32;33	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1088	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1996	29.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
